‘Off-the-Shelf’ CAR T Therapy Shows Early Activity in NHL

by | May 19, 2026 | Health

Spread the love
Researchers explore the safety and efficacy of an allogeneic CD19-targeted CAR T-cell immunotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma in a phase 1/2 study.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments